Back to Journals » Infection and Drug Resistance » Volume 15

Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman [Corrigendum]

Authors Al Battashi A, Al Harrassi B, Al Maskari N, Al Hashami H, Al Awaidy S 

Received 23 August 2022

Accepted for publication 23 August 2022

Published 30 August 2022 Volume 2022:15 Pages 4961—4962

DOI https://doi.org/10.2147/IDR.S387326



Al Battashi A, Al Harrassi B, Al Maskari N, Al Hashami H, Al Awaidy S. Infect Drug Resist. 2022;15:3939–3947.

The authors have advised there are errors in the in-text citations for Tables 2 and 3.

Page 3942, Microbial Etiology and Susceptibility Pattern section, first sentence, the text “Gram-negative organisms were more commonly grown (n = 42, 57%) in children receiving chemotherapeutic agents for cancer (Table 2)” should read “Gram-negative organisms were more commonly grown (n = 42, 57%) in children receiving chemotherapeutic agents for cancer (Table 3)”.

Page 3942, Microbial Etiology and Susceptibility Pattern section, second sentence, the text “Among the gram-positive organisms” should read “Among the gram-positive organisms (Table 2)”.

Page 3944, second paragraph, sixth sentence, the text “For gram-positive bacteria (Table 3)” should read “For gram-positive bacteria (Table 2)”.

The authors apologise for these errors.


Read the original article


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.